Indian Journal of Critical Care Case Report

Register      Login

VOLUME 3 , ISSUE 4 ( July-August, 2024 ) > List of Articles


Atypical Presentation of Macrophage Activation Syndrome Associated with Primary Sjogren's Syndrome

Rahul Kumar Amte, Saranya Chandrasegarane

Keywords : Autoimmune, Case report, H-score, Hemophagocytic lymphohistiocytosis

Citation Information : Amte RK, Chandrasegarane S. Atypical Presentation of Macrophage Activation Syndrome Associated with Primary Sjogren's Syndrome. 2024; 3 (4):97-101.

DOI: 10.5005/jp-journals-11006-0108

License: CC BY-NC 4.0

Published Online: 21-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Background: Macrophage activation syndrome (MAS) associated with Primary Sjogren's syndrome is a rare entity. The following are our observations on a patient of Indian origin who presented with features of cholestatic jaundice and was diagnosed with MAS. We also discuss the challenges faced during its management. Case description: A 53-year-old woman presented with generalized weakness and yellowish discoloration of skin, sclera, and urine for 1 month. She was evaluated for various etiologies of acute hepatitis. During this, the autoimmune profile was suggestive of Primary Sjogren's syndrome. Despite starting appropriate treatment, her liver dysfunction worsened, and her fever persisted. Further workup revealed high ferritin, triglycerides, and lactate dehydrogenase (LDH). Secondary hemophagocytic lymphohistiocytosis (sHLH) was suspected, and biopsies from the liver and bone marrow were performed. Macrophages, lymphocytes, and histiocytes were present in the marrow. Hence, she was diagnosed with MAS associated with portosystemic shunts (PSS) with liver dysfunction. She was treated with steroids, etoposide, cyclosporine, and intravenous immunoglobulin (IVIg). Despite best efforts, there was no clinical improvement, and she was discharged against medical advice. Six weeks later, she succumbed to her illness at home. Conclusion: Macrophage activation syndrome is a rare entity. The mortality is very high, especially when initial ferritin levels are elevated and also if they do not respond to steroids.

PDF Share
  1. Kane BS, Niasse M, Faye A, et al. Macrophage activation syndrome, a rare complication of primary Sjogren's syndrome: a case report. J Med Case Reports 2019;13(1):309. DOI: 10.1186/s13256-019-2252-z
  2. Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology 2019;58(1):5–17. DOI: 10.1093/rheumatology/key006
  3. García-Montoya L, Saenz-Tenorio CN, Janta I, et al. Hemophagocytic Lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review. Rheumatol Int 2017;37(4):663–669. DOI: 10.1007/s00296-016-3601-5
  4. Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol 2018;31(10):117–128. DOI: 10.2147/OARRR.S151013
  5. Warmoth T, Ramesh M, Iwuji K, et al. Macrophage activation syndrome in adults: a retrospective case series. J Investig Med High Impact Case Rep 2021;9:1–7. DOI: 10.1177/23247096211026406
  6. Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014:66(9):2613–2620. DOI: 10.1002/art.38690
  7. Androutsakos T, Voulgaris TA, Bakasis AD, et al. Liver fibrosis in Primary Sjogren's syndrome. Front Immunol 2022;13:889021. DOI: 10.3389/fimmu.2022.889021
  8. Lin S, Li Y, Long J, et al. Acute liver failure caused by hemophagocytic lymphohistiocytosis in adults: a case report and review of the literature. Medicine (Baltimore) 2016;95(47):e5431. DOI: 10.1097/MD.0000000000005431
  9. Salunke B, Savarkar S, Patil VP. Hemophagocytic Syndrome-an approach to the management. Indian J Crit Care Med 2019;23(Suppl 3):S191–S196. DOI: 10.5005/jp-journals-10071-23251
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.